ARCHIVES

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 18 No. 46 | November 27, 1992

Download PDF Visit The Full Archive

Related Articles

Reviewers Duck Problem Of Naming Four More Comprehensive Centers, Leave It Up To Rauscher To Pick From List Of 11

March 29, 1974

Adverse Events Of Chemo More Common Than Expected

August 25, 2006

Presidential Candidates Promise Increases In Funding For Cancer Research, Prevention.

September 14, 2007

Overhead Caused By Outreach, Other Federal Programs Threatens Cancer Centers, Durant Contends

November 5, 1976

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

May 30, 2014

DCT Board Approves Concepts For New CTEP, RRP Grants

February 24, 1989